Combination drug therapy for pain following chronic spinal cord injury

Pain Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Hama, Aldric ^a   Sagen, Jacqueline ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872730960     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2012/840486     Document Type: Review

References (167)

1. Millan M. J., The induction of pain: an integrative review. Progress in Neurobiology 1999 57 1 1 164 2-s2.0-0032890162 10.1016/S0301-0082(98)00048-3 (Pubitemid 28551764)
2. Hulsebosch C. E., Hains B. C., Crown E. D., Carlton S. M., Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Research Reviews 2009 60 1 202 213 2-s2.0-63449106099 10.1016/j.brainresrev.2008.12.010
3. Myers R. R., Campana W. M., Shubayev V. I., The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discovery Today 2006 11 1-2 8 20 2-s2.0-32444451323 10.1016/S1359-6446(05)03637-8 (Pubitemid 43227847)
4. Cesare P., McNaughton P., Peripheral pain mechanisms. Current Opinion in Neurobiology 1997 7 4 493 499 2-s2.0-0031426399 10.1016/S0959-4388(97)80028-1 (Pubitemid 28102556)
5. Sommer C., Kress M., Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neuroscience Letters 2004 361 1-3 184 187 2-s2.0-2342646193 10.1016/j.neulet. 2003.12.007 (Pubitemid 38609247)
6. Watkins L. R., Hutchinson M. R., Milligan E. D., Maier S. F., Listening and talking to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Research Reviews 2007 56 1 148 169 2-s2.0-36049011866 10.1016/j.brainresrev.2007.06.006 (Pubitemid 350100866)
7. Gosselin R. D., Suter M. R., Ji R. R., Decosterd I., Glial cells and chronic pain. Neuroscientist 2010 16 5 519 531 2-s2.0-77957568217 10.1177/1073858409360822
8. Price T. J., Cervero F., Gold M. S., Hammond D. L., Prescott S. A., Chloride regulation in the pain pathway. Brain Research Reviews 2009 60 1 149 170 2-s2.0-63449096743 10.1016/j.brainresrev.2008.12.015
9. Jaggi A. S., Singh N., nirmal puru@rediffmail.com Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS and Neurological Disorders 2011 10 5 589 609
10. Ji R. R., Gereau R. W. T., Malcangio M., Strichartz G. R., MAP kinase and pain. Brain Research Reviews 2009 60 1 135 148 2-s2.0-63449113568 10.1016/j.brainresrev.2008.12.011
11. Hirayama T., Dostrovsky J. O., Gorecki J., Tasker R. R., Lenz F. A., Recordings of abnormal activity in patients with deafferentiation and central pain. Stereotactic and Functional Neurosurgery 1989 52 2-4 120 126 2-s2.0-0024501879 (Pubitemid 19125226)
12. Sotgiu M. L., Biella G., Castagna A., Lacerenza M., Marchettini P., Different time-courses of i.v. lidocaine effect on ganglionic and spinal units in neuropathic rats. NeuroReport 1994 5 8 873 876 2-s2.0-0028329251 (Pubitemid 24138087)
13. Gracely R. H., Lynch S. A., Bennett G. J., Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992 51 2 175 194 2-s2.0-0026621804 10.1016/0304-3959(92)90259-E (Pubitemid 23000733)
14. Gwak Y. S., Hulsebosch C. E., cehulseb@utmb.edu Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury. Current Pain and Headache Reports 2011 15 3 215 222 10.1007/s11916-011- 0186-2
15. Hains B. C., Saab C. Y., Waxman S. G., Changes in electrophysiological properties and sodium channel Na v1.3 expression in thalamic neurons after spinal cord injury. Brain 2005 128 10 2359 2371 2-s2.0-26044434843 10.1093/brain/awh623 (Pubitemid 41407975)
16. Anderson W. S., O'Hara S., Lawson H. C., Treede R. D., Lenz F. A., Plasticity of pain-related neuronal activity in the human thalamus. Progress in Brain Research 2006 157 353 364 2-s2.0-33749628545 10.1016/S0079-6123(06)57021-9 (Pubitemid 44548605)
17. Endo T., Spenger C., Hao J., Tominaga T., Wiesenfeld-Hallin Z., Olson L., Xu X. J., Functional MRI of the brain detects neuropathic pain in experimental spinal cord injury. Pain 2008 138 2 292 300 2-s2.0-49049083855 10.1016/j.pain.2007.12.017
18. Wrigley P. J., Press S. R., Gustin S. M., Macefield V. G., Gandevia S. C., Cousins M. J., Middleton J. W., Henderson L. A., Siddall P. J., Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain 2009 141 1-2 52 59 2-s2.0-58149163278 10.1016/j.pain.2008.10.007
19. Wang J., Kawamata M., Namiki A., Changes in properties of spinal dorsal horn neurons and their sensitivity to morphine after spinal cord injury in the rat. Anesthesiology 2005 102 1 152 164 2-s2.0-11444262902 10.1097/00000542- 200501000-00024 (Pubitemid 40082852)
20. Falci S., Best L., Bayles R., Lammertse D., Starnes C., Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome. Journal of Neurosurgery 2002 97 2 193 200 2-s2.0-0036726988
21. Yaksh T. L., Hua X. Y., Kalcheva I., Nozaki-Taguchi N., Marsala M., The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7680 7686 2-s2.0-0033529223 10.1073/pnas.96.14.7680 (Pubitemid 29328340)
22. Borsook D., Becerra L., Hargreaves R., Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions. Discovery medicine 2011 11 58 197 207
23. Pattany P. M., Yezierski R. P., Widerström-Noga E. G., Bowen B. C., Martinez-Arizala A., Garcia B. R., Quencer R. M., Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. American Journal of Neuroradiology 2002 23 6 901 905 2-s2.0-0036083882 (Pubitemid 34663428)
24. Gilron I., Max M. B., Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Review of Neurotherapeutics 2005 5 6 823 830 2-s2.0-27944437043 10.1586/14737175.5.6.823 (Pubitemid 41679649)
25. Mao J., Gold M. S., Backonja M. M., Combination drug therapy for chronic pain: a call for more clinical studies. Journal of Pain 2011 12 2 157 166 2-s2.0-77956514374 10.1016/j.jpain.2010.07.006
26. Berenbaum M. C., What is synergy? Pharmacological Reviews 1989 41 2 93 141 2-s2.0-0024847290 (Pubitemid 20019599)
27. Tallarida R. J., Interactions between drugs and occupied receptors. Pharmacology and Therapeutics 2007 113 1 197 209 2-s2.0-33845716253 10.1016/j.pharmthera.2006.08.002 (Pubitemid 44969929)
28. Tallarida R. J., Raffa R. B., Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. Life Sciences 1995 58 2 PL23 PL28 2-s2.0-0030026024 (Pubitemid 126635405)
29. Raffa R. B., Clark-Vetri R., Tallarida R. J., Wertheimer A. I., Combination strategies for pain management. Expert Opinion on Pharmacotherapy 2003 4 10 1697 1708 2-s2.0-0142210237 10.1517/14656566.4.10.1697 (Pubitemid 37322355)
30. 2-inhibitors in nerve-injured rats. Pain 1999 82 1 65 72 2-s2.0-0032995478 10.1016/S0304- 3959(99)00031-7 (Pubitemid 29287087)
31. Hama A. T., Lloyd G. K., Menzaghi F., The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats. Pain 2001 91 1-2 131 138 2-s2.0-0035059685 10.1016/S0304-3959(00)00425-5 (Pubitemid 32279618)
32. Larson A. A., Vaught J. L., Takemori A. E., The potentiation of spinal analgesia by leucine enkephalin. European Journal of Pharmacology 1980 61 4 381 383 2-s2.0-0018840934 (Pubitemid 10156077)
33. The National Spinal Cord Injury Statistical Center,. 2011, https://www.nscisc.uab.edu/public content/pdf/Facts%202011%20Feb%20Final.pdf
34. Samsa G. P., Patrick C. H., Feussner J. R., Long-term survival of veterans with traumatic spinal cord injury. Archives of Neurology 1993 50 9 909 914 2-s2.0-0027181508 (Pubitemid 23275118)
35. Devivo M. J., Chen Y., yychen@uab.edu Trends in new injuries, prevalent cases, and aging with spinal cord injury. Archives of Physical Medicine and Rehabilitation 2011 92 3 332 338 10.1016/j.apmr.2010.08.031
36. Hitzig S. L., Campbell K. A., McGillivray C. F., Boschen K. A., Craven B. C., Understanding age effects associated with changes in secondary health conditions in a Canadian spinal cord injury cohort. Spinal Cord 2010 48 4 330 335 2-s2.0-77950520153 10.1038/sc.2009.135
37. Christo P. J., Li S., Gibson S. J., Fine P., Hameed H., Effective treatments for pain in the older patient. Current Pain and Headache Reports 2011 15 1 22 34 2-s2.0-78650192224 10.1007/s11916-010-0164-0
38. Kaye A. D., Baluch A., Scott J. T., Pain management in the elderly population: a review. Ochsner Journal 2010 10 3 179 187 2-s2.0-77957326623
39. Eide P. K., Pathophysiological mechanisms of central neuropathic pain after spinal cord injury. Spinal Cord 1998 36 9 601 612 2-s2.0-0031664003 (Pubitemid 28434588)
40. Nicholson B. D., Evaluation and treatment of central pain syndromes. Neurology 2004 62 5, supplement 2 S30 S36 2-s2.0-1542286071 (Pubitemid 38298936)
41. Baastrup C., Finnerup N. B., Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs 2008 22 6 455 475 2-s2.0-43749114717 10.2165/00023210-200822060-00002 (Pubitemid 351693689)
42. Finnerup N. B., Jensen T. S., Spinal cord injury pain-mechanisms and treatment. European Journal of Neurology 2004 11 2 73 82 2-s2.0-1242314826 10.1046/j.1351-5101.2003.00725.x (Pubitemid 38230781)
43. Finnerup N. B., Gyldensted C., Nielsen E., Kristensen A. D., Bach F. W., Jensen T. S., MRI in chronic spinal cord injury patients with and without central pain. Neurology 2003 61 11 1569 1575 2-s2.0-0344738664 (Pubitemid 37505581)
44. Finnerup N. B., Sorensen L., Biering-Sorensen F., Johannesen I. L., Jensen T. S., Segmental hypersensitivity and spinothalamic function in spinal cord injury pain. Experimental Neurology 2007 207 1 139 149 2-s2.0-34548204317 10.1016/j.expneurol.2007.06.001 (Pubitemid 47332490)
45. Eide P. K., Jorum E., Stenehjem A. E., Somatosensory findings in patients with spinal cord injury and central dysaesthesia pain. Journal of Neurology Neurosurgery and Psychiatry 1996 60 4 411 415 2-s2.0-0029935366 (Pubitemid 26118749)
46. Rabchevsky A. G., Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury. Progress in Brain Research 2005 152 265 274 2-s2.0-25844459665 10.1016/S0079-6123(05)52017-X (Pubitemid 41392868)
47. Cardenas D. D., Warms C. A., Turner J. A., Marshall H., Brooke M. M., Loeser J. D., Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002 96 3 365 373 2-s2.0-0036222008 10.1016/S0304-3959(01)00483-3 (Pubitemid 34327885)
48. Tremont-Lukats I. W., Challapalli V., McNicol E. D., Lau J., Carr D. B., Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesthesia and Analgesia 2005 101 6 1738 1749 2-s2.0-28444445248 10.1213/01.ANE.0000186348.86792.38 (Pubitemid 41722151)
49. Teasell R. W., Mehta S., Aubut J. A., Foulon B., Wolfe D. L., Hsieh J. T. C., Townson A. F., Short C., A systematic review of pharmacologic treatments of pain after spinal cord injury. Archives of Physical Medicine and Rehabilitation 2010 91 5 816 831 2-s2.0-77951263105 10.1016/j.apmr.2010.01.022
50. Hama A., Sagen J., Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression. Brain Research 2007 1185 1 117 128 2-s2.0-36448959087 10.1016/j.brainres.2007.09.013 (Pubitemid 350166306)
51. Hama A., Gajavelli S., Sagen J., Herkowitz H. N., Garfin S. R., Eismont F. J., Bell G. R., Balderston R. A., Chronic pain: the basic science. Rothman Simeone The Spine 2011 6th Philadelphia, Pa, USA Elsevier 900 917
52. Basso D. M., Beattie M. S., Bresnahan J. C., Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Experimental Neurology 1996 139 2 244 256 2-s2.0-0030157694 10.1006/exnr.1996.0098 (Pubitemid 26228093)
53. Bunge R. P., Puckett W. R., Becerra J. L., Marcillo A., Quencer R. M., Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Advances in Neurology 1993 59 75 89 2-s2.0-0027343542
54. Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M., Yaksh T. L., Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 1994 53 1 55 63 2-s2.0-0027933374 10.1016/0165-0270(94) 90144-9 (Pubitemid 24238751)
55. Hargreaves K., Dubner R., Brown F., Flores C., Joris J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988 32 1 77 88 2-s2.0-0023924046
56. Finnerup N. B., Johannesen I. L., Fuglsang-Frederiksen A., Bach F. W., Jensen T. S., Sensory function in spinal cord injury patients with and without central pain. Brain 2003 126 1 57 70 2-s2.0-0037224588 10.1093/brain/awg007 (Pubitemid 36068560)
57. Henze D. A., Urban M. O., Kruger L., Light A. R., Large animal models for pain therapeutic development. Translational Pain Research: From Mouse to Man 2010 Boca Raton, Fla, USA CRC Press 371 390
58. Plummer J. L., Cmielewski P. L., Gourlay G. K., Owen H., Cousins M. J., Assessment of antinociceptive drug effects in the presence of impaired motor performance. Journal of Pharmacological Methods 1991 26 1 79 87 2-s2.0-0025873614 10.1016/0160-5402(91)90057-C
59. Xu X. J., Hao J. X., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z., Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 1992 48 2 279 290 2-s2.0-0026501374 10.1016/0304-3959(92)90070-R
60. De Vry J., Kuhl E., Franken-Kunkel P., Eckel G., Pharmacological characterization of the chronic constriction injury model of neuropathic pain. European Journal of Pharmacology 2004 491 2-3 137 148 2-s2.0-2342446466 10.1016/j.ejphar.2004.03.051 (Pubitemid 38609471)
61. Widerström-Noga E. G., Turk D. C., Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristics. Spinal Cord 2003 41 11 600 609 2-s2.0-18544411408 10.1038/sj.sc.3101511 (Pubitemid 37386445)
62. Hao J. X., Xu X. J., Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists. Pain 1996 66 2-3 279 285 2-s2.0-0030220802 10.1016/0304-3959(96)03019-9 (Pubitemid 26283998)
63. Hao J. X., Xu X. J., Yu Y. X., Seiger A., Wiesenfeld-Hallin Z., Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia; Implications for a tonic GABAergic inhibitory control of myelinated fiber input. Journal of Neurophysiology 1992 68 2 392 396 2-s2.0-0026783882
64. Hao J. X., Xu X. J., Urban L., Wiesenfeld-Hallin Z., Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neuroscience Letters 2000 280 3 211 214 2-s2.0-0033974911 10.1016/S0304-3940(00)00787-4 (Pubitemid 30089838)
65. Hama A. T., Borsook D., The effect of antinociceptive drugs tested at different times after nerve injury in rats. Anesthesia and Analgesia 2005 101 1 175 179 2-s2.0-20744441093 10.1213/01.ANE.0000155247.93604.62 (Pubitemid 40853372)
66. Apaydin S., Uyar M., Karabay N. U., Erhan E., Yegul I., Tuglular I., The antinociceptive effect of tramadol on a model of neuropathic pain in rats. Life Sciences 2000 66 17 1627 1637 2-s2.0-0034677839 10.1016/S0024-3205(00)00482-3 (Pubitemid 30170122)
67. Tsai Y. C., Sung Y. H., Chang P. J., Kang F. C., Chu K. S., Tramadol relieves thermal hyperalgesia in rats with chronic constriction injury of the sciatic nerve. Fundamental and Clinical Pharmacology 2000 14 4 335 340 2-s2.0-0033816591
68. Hama A., Sagen J., Altered antinociceptive efficacy of tramadol over time in rats with painful peripheral neuropathy. European Journal of Pharmacology 2007 559 1 32 37 2-s2.0-33847071314 10.1016/j.ejphar.2006.11.047 (Pubitemid 46274643)
69. Raffa R. B., Friderichs E., Reimann W., Shank R. P., Codd E. E., Vaught J. L., Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics 1992 260 1 275 285 2-s2.0-0026512239
70. Monasky M. S., Zinsmeister A. R., Stevens C. W., Yaksh T. L., Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. Journal of Pharmacology and Experimental Therapeutics 1990 254 2 383 392 2-s2.0-0025079253 (Pubitemid 20262070)
71. Taiwo Y. O., Fabian A., Pazoles C. J., Fields H. L., Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 1985 21 4 329 337 2-s2.0-0021996235 10.1016/0304-3959(85)90162-9 (Pubitemid 15093083)
72. Kishimoto K., Koyama S., Akaike N., Synergistic μ -opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacology 2001 41 5 529 538 2-s2.0-0034816216 10.1016/S0028-3908(01) 00100-9 (Pubitemid 32924962)
73. Calcutt C. R., Spencer P. S., Activities of narcotic and narcotic-antagonist analgesics following the intraventricular injection of various substances. British Journal of Pharmacology 1971 41 2 401P 402P 2-s2.0-17144434628
74. Carlton S. M., Peripheral NMDA receptors revisited-hope floats. Pain 2009 146 1-2 1 2 2-s2.0-70349783786 10.1016/j.pain.2009.08.011
75. Omote K., Namiki A., Interaction between opiates and neurotransmitters/ neuromodulators in spinal analgesia. Masui 1992 41 5 712 720 2-s2.0-0026769126
76. Bennett G., Serafini M., Burchiel K., Buchser E., Classen A., Deer T., Du Pen S., Ferrante F. M., Hassenbusch S. J., Lou L., Maeyaert J., Penn R., Portenoy R. K., Rauck R., Willis K. D., Yaksh T., Evidence-based review of the literature on intrathecal delivery of pain medication. Journal of Pain and Symptom Management 2000 20 2, supplement S12 S36 2-s2.0-0033832189 10.1016/S0885-3924(00)00204-9
77. von Heijne M., Hao J. X., Sollevi A., Xu X. J., Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats. European Journal of Pain 2001 5 1 1 10 2-s2.0-0034922906 10.1053/eujp.2000.0212
78. Boroujerdi A., Zeng J., Sharp K., Kim D., Steward O., Luo Z. D., zluo@uci.edu Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 2011 152 3 649 655 10.1016/j.pain.2010.12.014
79. Gwak Y. S., ysgwak@utmb.edu Tan H. Y., Nam T. S., Paik K. S., Hulsebosch C. E., Leem J. W., jwleem@yumc.yonsei.ac.kr Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. Journal of Neurotrauma 2006 23 7 1111 1124 10.1089/neu.2006.23.1111 (Pubitemid 44162716)
80. Bennett A. D., Everhart A. W., Hulsebosch C. E., Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Research 2000 859 1 72 82 2-s2.0-0034678026 10.1016/S0006-8993(99)02483-X (Pubitemid 30138194)
81. Hama A., Lee J. W., Sagen J., Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats. European Journal of Pharmacology 2003 459 1 49 58 2-s2.0-0037427965 10.1016/S0014-2999(02)02828-5 (Pubitemid 36044614)
82. Chaplan S. R., Malmberg A. B., Yaksh T. L., Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. Journal of Pharmacology and Experimental Therapeutics 1997 280 2 829 838 2-s2.0-0030933616 (Pubitemid 27171346)
83. Medvedev I. O., Malyshkin A. A., Belozertseva I. V., Sukhotina I. A., Sevostianova N. Y., Aliev K., Zvartau E. E., Parsons C. G., Danysz W., Bespalov A. Y., Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neuropharmacology 2004 47 2 175 183 2-s2.0-3042608098 10.1016/j.neuropharm.2004.01.019 (Pubitemid 38824641)
84. Herman R. M., D'Luzansky S. C., Ippolito R., Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clinical Journal of Pain 1992 8 4 338 345 2-s2.0-0027103035 (Pubitemid 23039034)
85. Taira T., Kawamura H., Tanikawa T., Iseki H., Kawabatake H., Takakura K., A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotactic and Functional Neurosurgery 1995 65 1-4 101 105 2-s2.0-0029551280 10.1159/000098905 (Pubitemid 26344506)
86. Ando Y., Hojo M., Kanaide M., Takada M., Sudo Y., Shiraishi S., Sumikawa K., Uezono Y., yuezono@ncc.go.jp S(+)-ketamine suppresses desensitization of γ -aminobutyric acid type B receptor-mediated signaling by inhibition of the interaction of γ -aminobutyric acid type B receptors with G protein-coupled receptor kinase 4 or 5. Anesthesiology 2011 114 2 401 411 10.1097/ALN.0b013e318204e003
87. Heetla H. W., Staal M. J., Kliphuis C., van Laar T., The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009 47 10 751 756 2-s2.0-70349739359 10.1038/sc.2009.34
88. Bellinger A., Siriwetchadarak R., Rosenquist R., Greenlee J. D. W., Prevention of intrathecal baclofen withdrawal syndrome successful use of a temporary intrathecal catheter. Regional Anesthesia and Pain Medicine 2009 34 6 600 602 2-s2.0-74549220408 10.1097/AAP.0b013e3181b4cc6b
89. Zhang A. L., Hao J. X., Seiger A., Xu X. J., Wiesenfeld-Hallin Z., Grant G., Aldskogius H., Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Research 1994 656 1 187 190 2-s2.0-0027931856 10.1016/0006-8993(94)91383-8 (Pubitemid 24263047)
90. Drew G. M., Siddall P. J., Duggan A. W., Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 2004 109 3 379 388 2-s2.0-2442432825 10.1016/j.pain.2004.02.007 (Pubitemid 38638715)
91. 3H]dopamine release from mesencephalic cell cultures. European Journal of Pharmacology 1994 264 3 361 369 2-s2.0-0028171883 10.1016/0014-2999(94)00492-7 (Pubitemid 24335478)
92. Rauck R. L., Wallace M. S., Burton A. W., Kapural L., North J. M., Intrathecal ziconotide for neuropathic pain: a review. Pain Practice 2009 9 5 327 337 2-s2.0-70349803503 10.1111/j.1533-2500.2009.00303.x
93. Hama A., Sagen J., Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain. Neuropharmacology 2009 56 556 563 2-s2.0-58549085757 10.1016/j.neuropharm.2008. 10.008
94. Saulino M., Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report. Spinal Cord 2007 45 11 749 752 2-s2.0-35948950266 10.1038/sj.sc.3102027 (Pubitemid 350071053)
95. Vanegas H., Schaible H., Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 2000 85 1-2 9 18 2-s2.0-0033969834 10.1016/S0304-3959(99)00241-9 (Pubitemid 30110739)
96. Chaplan S. R., Pogrel J. W., Yaksh T. L., Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. Journal of Pharmacology and Experimental Therapeutics 1994 269 3 1117 1123 2-s2.0-0028335910 (Pubitemid 24204194)
97. Scott D. A., Wright C. E., Angus J. A., Actions of intrathecal ω -conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. European Journal of Pharmacology 2002 451 3 279 286 2-s2.0-0037144134 10.1016/S0014-2999(02)02247-1 (Pubitemid 35254031)
98. Penn R. D., Paice J. A., Adverse effects associated with the intrathecal administration of ziconotide. Pain 2000 85 1-2 291 296 2-s2.0-0033952153 10.1016/S0304-3959(99)00254-7 (Pubitemid 30110772)
99. Malmberg A. B., Gilbert H., McCabe R. T., Basbaum A. I., Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 2003 101 1-2 109 116 2-s2.0-0037219288 10.1016/S0304-3959(02)00303-2 (Pubitemid 36044658)
100. Teichert R. W., Olivera B. M., Natural products and ion channel pharmacology. Future Medicinal Chemistry 2010 2 5 731 744 2-s2.0-77953391048 10.4155/fmc.10.31
101. Heimann A. S., Gomes I., Dale C. S., Pagano R. L., Gupta A., De Souza L. L., Luchessi A. D., Castro L. M., Giorgi R., Rioli V., Ferro E. S., Devi L. A., Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proceedings of the National Academy of Sciences of the United States of America 2007 104 51 20588 20593 2-s2.0-38049117749 10.1073/pnas.0706980105
102. Mechoulam R., Mechoulam R., The pharmacohistory of Cannabis sativa. Cannabinoids as Therapeutic Agents 1986 Boca Raton, Fla, USA CRC Press 1 19
103. Rahn E. J., Hohmann A. G., Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics 2009 6 4 713 737 2-s2.0-70349333074 10.1016/j.nurt.2009.08.002
104. Pertwee R. G., Pharmacological actions of cannabinoids. Handbook of Experimental Pharmacology 2005 168 1 51 2-s2.0-31144449705
105. Welch S. P., Stevens D. L., Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. Journal of Pharmacology and Experimental Therapeutics 1992 262 1 10 18 2-s2.0-0026639295
106. Tham S. M., Angus J. A., Tudor E. M., Wright C. E., Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α 2-adrenoceptor agonists in acute pain models in mice. British Journal of Pharmacology 2005 144 6 875 884 2-s2.0-17144401168 10.1038/sj.bjp.0706045 (Pubitemid 40516127)
107. Kang S., Kim C. H., Lee H., Kim D. Y., Han J. I., Chung R. K., Lee G. Y., Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test. Anesthesia and Analgesia 2007 104 3 719 725 2-s2.0-33847231287 10.1213/01.ane.0000255291.38637.26
108. Campbell F. A., Tramèr M. R., Carroll D., Reynolds D. J., Moore R. A., McQuay H. J., Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. British Medical Journal 2001 323 7303 13 16 2-s2.0-0035822343 (Pubitemid 32681998)
109. Rintala D. H., Fiess R. N., Tan G., Holmes S. A., Bruel B. M., Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. American Journal of Physical Medicine and Rehabilitation 2010 89 10 840 848 2-s2.0-77957567663 10.1097/PHM.0b013e3181f1c4ec
110. Iskedjian M., Bereza B., Gordon A., Piwko C., Einarson T. R., Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Current Medical Research and Opinion 2007 23 1 17 24 2-s2.0-33846662156 10.1185/030079906X158066 (Pubitemid 46191666)
111. Pertwee R. G., Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology and Therapeutics 1997 74 2 129 180 2-s2.0-0030611978 10.1016/S0163-7258(97)82001-3 (Pubitemid 27337346)
112. Kinsey S. G., Long J. Z., O'Neal S. T., Abdullah R. A., Poklis J. L., Boger D. L., Cravatt B. F., Lichtman A. H., Blockade of endocannabinoid- degrading enzymes attenuates neuropathic pain. Journal of Pharmacology and Experimental Therapeutics 2009 330 3 902 910 2-s2.0-70349110145 10.1124/jpet.109.155465
113. Chang L., Luo L., Palmer J. A., Sutton S., Wilson S. J., Barbier A. J., Breitenbucher J. G., Chaplan S. R., Webb M., Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. British Journal of Pharmacology 2006 148 1 102 113 2-s2.0-33646407548 10.1038/sj.bjp.0706773 (Pubitemid 43675606)
114. Ahn K., Johnson D. S., Mileni M., Beidler D., Long J. Z., McKinney M. K., Weerapana E., Sadagopan N., Liimatta M., Smith S. E., Lazerwith S., Stiff C., Kamtekar S., Bhattacharya K., Zhang Y., Swaney S., Van Becelaere K., Stevens R. C., Cravatt B. F., Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chemistry and Biology 2009 16 4 411 420 2-s2.0-64749114255 10.1016/j.chembiol.2009.02.013
115. Jayamanne A., Greenwood R., Mitchell V. A., Aslan S., Piomelli D., Vaughan C. W., Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. British Journal of Pharmacology 2006 147 3 281 288 2-s2.0-32244432341 10.1038/sj.bjp.0706510 (Pubitemid 43214685)
116. 4 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. Journal of Biological Chemistry 2005 280 36 31405 31412 10.1074/jbc.M501489200 (Pubitemid 41291881)
117. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., Leone S., Paracetamol: new vistas of an old drug. CNS Drug Reviews 2006 12 3-4 250 275 2-s2.0-33846008062 10.1111/j.1527-3458.2006.00250.x (Pubitemid 46047791)
118. Prescott L. F., Therapeutic misadventure with paracetamol: fact or fiction? American Journal of Therapeutics 2000 7 2 99 114 2-s2.0-0034157944
119. Raffa R. B., Pergolizzi J. V., Segarnick D. J., Tallarida R. J., Oxycodone combinations for pain relief. Drugs of Today 2010 46 6 379 398 2-s2.0-77955441904 10.1358/dot.2010.46.6.1470106
120. Hama A. T., Sagen J., Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology 2010 58 4-5 758 766 2-s2.0-77649339063 10.1016/j.neuropharm.2009.12.010
121. Hentall I. D., Sagen J., The alleviation of pain by cell transplantation. Progress in Brain Research 2000 127 535 550 2-s2.0-0034589759 10.1016/S0079-6123(00)27027-1 (Pubitemid 35461276)
122. Jeon Y., jeon68@knu.ac.kr Cell based therapy for the management of chronic pain. Korean Journal of Anesthesiology 2011 60 1 3 7 10.4097/kjae.2011.60.1.3
123. Eaton M. J., Wolfe S. Q., Clinical feasibility for cell therapy using human neuronal cell line to treat neuropathic behavioral hypersensitivity following spinal cord injury in rats. Journal of Rehabilitation Research and Development 2009 46 1 145 166 2-s2.0-65949093032 10.1682/JRRD.2008.02.0018
124. 1] histogranin. Pharmacology Biochemistry and Behavior 1995 50 1 49 54 2-s2.0-0028890254 10.1016/0091-3057(94)00247-G
125. Siegan J. B., Hama A. T., Sagen J., Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. Brain Research 1997 755 2 331 334 2-s2.0-0030944381 10.1016/S0006-8993(97)00183-2 (Pubitemid 27196339)
126. Mao J., Price D. D., Mayer D. J., Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995 61 3 353 364 2-s2.0-0029077507 10.1016/0304-3959(95)00022-K
127. Black D. R., Sang C. N., Advances and limitations in the evaluation of analgesic combination therapy. Neurology 2005 65 12, supplement 4 S3 S6 2-s2.0-33645049361
128. Siddall P. J., Molloy A. R., Walker S., Mather L. E., Rutkowski S. B., Cousins M. J., The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesthesia and Analgesia 2000 91 6 1493 1498 2-s2.0-0033677167
129. Saulino M., Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience. European Journal of Physical and Rehabilitation Medicine. In press
130. Middleton J. W., Siddall P. J., Walker S., Molloy A. R., Rutkowski S. B., Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Archives of Physical Medicine and Rehabilitation 1996 77 8 824 826 2-s2.0-0029810150 10.1016/S0003-9993(96)90264-6 (Pubitemid 26262384)
131. Saulino M., Burton A. W., Danyo D. A., Frost S., Glanzer J., Solanki D. R., Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports. European Journal of Physical and Rehabilitation Medicine 2009 45 1 61 67 2-s2.0-67650459927
132. Amr Y. M., Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial. Pain Physician 2010 13 3 245 249 2-s2.0-77953444666
133. Berry J. D., Petersen K. L., A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005 65 3 444 447 2-s2.0-23244448919 10.1212/01.WNL.0000168259.94991.8a (Pubitemid 41099809)
134. Kress H. G., Simpson K. H., Marchettini P., Ver Donck A., Varrassi G., Intrathecal therapy: what has changed with the introduction of ziconotide. Pain Practice 2009 9 5 338 347 2-s2.0-77952237542 10.1111/j.1533-2500.2009.00308.x
135. Bedi S. S., Yang Q., Crook R. J., Du J., Wu Z., Fishman H. M., Grill R. J., Carlton S. M., Walters E. T., Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury. Journal of Neuroscience 2010 30 44 14870 14882 2-s2.0-78049513095 10.1523/JNEUROSCI.2428-10.2010
136. Wasner G., Naleschinski D., Baron R., A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report. Pain 2007 131 1-2 219 225 2-s2.0-34547501308 10.1016/j.pain.2007.03.005 (Pubitemid 47187894)
137. Kopsky D. J., Keppel Hesselink J. M., A new combination cream for the treatment of severe neuropathic pain. Journal of Pain and Symptom Management 2010 39 2 e9 e10 2-s2.0-75749126154 10.1016/j.jpainsymman.2009.09.004
138. Kopsky D. J., info@neuropathie.nu Keppel Hesselink J. M., High doses of topical amitriptyline in neuropathic pain: two cases and literature review. Pain Practice 2012 12 1 1 3 10.1111/j.1533-2500.2011.00477.x
139. Hans G., Sabatowski R., Binder A., Boesl I., Rogers P., Baron R., Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Current Medical Research and Opinion 2009 25 5 1295 1305 2-s2.0-67549145359 10.1185/03007990902901368
140. Joshi S. K., Honore P., Hernandez G., Schmidt R., Gomtsyan A., Scanio M., Kort M., Jarvis M. F., Additive antinociceptive effects of the selective nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models. Journal of Pain 2009 10 3 306 315 2-s2.0-60849123747 10.1016/j.jpain.2008.09.007
141. Hama A. T., Plum A. W., Sagen J., Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain. Pharmacology Biochemistry and Behavior 2010 97 2 249 255 2-s2.0-77957762375 10.1016/j.pbb.2010.08.006
142. Finnerup N. B., Pedersen L. H., Terkelsen A. J., Johannesen I. L., Jensen T. S., Reaction to topical capsaicin in spinal cord injury patients with and without central pain. Experimental Neurology 2007 205 1 190 200 2-s2.0-34247232169 10.1016/j.expneurol.2007.01.026 (Pubitemid 46617503)
143. Roerig S. C., O'Brien S. M., Fujimoto J. M., Wilcox G. L., Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Research 1984 308 2 360 363 2-s2.0-0021191841 10.1016/0006-8993(84)91078-3 (Pubitemid 14061971)
144. Raffa R. B., Stone D. J. Jr., Tallarida R. J., Discovery of self-synergistic spinal/supraspinal antinociception produced by acetaminophen (paracetamol). Journal of Pharmacology and Experimental Therapeutics 2000 295 1 291 294 2-s2.0-0033803398
145. Hentall I. D., Burns S. B., Restorative effects of stimulating medullary raphe after spinal cord injury. Journal of Rehabilitation Research and Development 2009 46 1 109 122 2-s2.0-69449104887
146. Previnaire J. G., Nguyen J. P., Perrouin-Verbe B., Fattal C., Chronic neuropathic pain in spinal cord injury: efficiency of deep brain and motor cortex stimulation therapies for neuropathic pain in spinal cord injury patients. Annals of Physical and Rehabilitation Medicine 2009 52 2 188 193 2-s2.0-65249109373 10.1016/j.rehab.2008.12.002
147. Midha M., Schmitt J. K., Epidural spinal cord stimulation for the control of spasticity in spinal cord injury patients lacks long-term efficacy and is not cost-effective. Spinal Cord 1998 36 3 190 192 2-s2.0-0031912023 (Pubitemid 28120697)
148. Song Z., zhiyang.song@ki.se Meyerson B. A., Linderoth B., The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy. Anesthesia and Analgesia 2011 113 5 1260 1265 10.1213/ANE.0b013e3182288851
149. Lind G., Schechtmann G., Winter J., Meyerson B. A., Linderoth B., Baclofen-enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain:. long-term outcome of a pilot study. European Journal of Pain 2008 12 1 132 136 2-s2.0-35748943540 10.1016/j.ejpain.2007.03.011 (Pubitemid 350046366)
150. Cuatrecasas P., Drug discovery in jeopardy. Journal of Clinical Investigation 2006 116 11 2837 2842 2-s2.0-33750579770 10.1172/JCI29999 (Pubitemid 44684465)
151. Hofstetter C. P., Holmström N. A., Lilja J. A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S. N., Frisén J., Olson L., Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neuroscience 2005 8 3 346 353 2-s2.0-20044370811 10.1038/nn1405 (Pubitemid 40300192)
152. Vaquero J., Zurita M., Oya S., Santos M., Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neuroscience Letters 2006 398 1-2 129 134 2-s2.0-33646366471 10.1016/j.neulet.2005.12.072
153. Fitzgerald M., Woolf C. J., Shortland P., Collateral sprouting of the central terminals of cutaneous primary afferent neurons in the rat spinal cord: pattern, morphology, and influence of targets. Journal of Comparative Neurology 1990 300 3 370 385 2-s2.0-0025086294 (Pubitemid 20357794)
154. Ackery A. D., Norenberg M. D., Krassioukov A., Calcitonin gene-related peptide immunoreactivity in chronic human spinal cord injury. Spinal Cord 2007 45 10 678 686 2-s2.0-34948902263 10.1038/sj.sc.3102020 (Pubitemid 47530646)
155. Chai E., Horton J. R., Managing pain in the elderly population: pearls and pitfalls. Current Pain and Headache Reports 2010 14 6 409 417 2-s2.0-78649909295 10.1007/s11916-010-0148-0
156. Gwak Y. S., Hains B. C., Johnson K. M., Hulsebosch C. E., Effect of age at time of spinal cord injury on behavioral outcomes in rat. Journal of Neurotrauma 2004 21 8 983 993 2-s2.0-4143078037 10.1089/0897715041650999 (Pubitemid 39096849)
157. Tanck E. N., Kroin J. S., McCarthy R. J., Penn R. D., Ivankovich A. D., Effects of age and size on development of allodynia in a chronic pain model produced by sciatic nerve ligation in rats. Pain 1992 51 3 313 316 2-s2.0-0026676409 10.1016/0304-3959(92)90215-W (Pubitemid 23005868)
158. Kim Y. I., Na H. S., Yoon Y. W., Nahm S. H., Ko K. H., Hong S. K., Mechanical allodynia is more strongly manifested in older rats in an experimental model of peripheral neuropathy. Neuroscience Letters 1995 199 2 158 160 2-s2.0-0028839757 10.1016/0304-3940(95)12038-6
159. Christensen M. D., Hulsebosch C. E., Chronic central pain after spinal cord injury. Journal of Neurotrauma 1997 14 8 517 537 2-s2.0-0030879294 (Pubitemid 27377660)
160. Detloff M. R., Fisher L. C., McGaughy V., Longbrake E. E., Popovich P. G., Basso D. M., Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Experimental Neurology 2008 212 2 337 347 2-s2.0-47349092661 10.1016/j.expneurol.2008.04.009
161. King C. D., Devine D. P., Vierck C. J., Rodgers J., Yezierski R. P., Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Research 2003 987 2 214 222 2-s2.0-0142134106 10.1016/S0006-8993(03)03339-0 (Pubitemid 37281436)
162. Davoody L., Quiton R. L., Lucas J. M., Ji Y., Keller A., Masri R., Radi.masri@gmail.com Conditioned place preference reveals tonic pain in an animal model of central pain. The Journal of Pain 2011 12 8 868 874 10.1016/j.jpain.2011.01.010
163. Baastrup C., Maersk-Moller C. C., Nyengaard J. R., Jensen T. S., Finnerup N. B., Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior. Pain 2010 151 3 670 679 2-s2.0-78049477607 10.1016/j.pain.2010.08.024
164. Craig A. D., A rat is not a monkey is not a human: comment on Mogil. Nature Reviews Neuroscience 2009 10 283 294. Nature Reviews Neuroscience, vol. 10, no. 6, pp. 466, 2009 2-s2.0-66249127207
165. Penn D. C., Povinelli D. J., On the lack of evidence that non-human animals possess anything remotely resembling a theory of mind Philosophical Transactions of the Royal Society B 2007 362 1480 731 744 2-s2.0-34447341188 10.1098/rstb.2006.2023 (Pubitemid 47056837)
166. Nagel T., What is it like to be a bat? Philosophical Review 1974 83 4 435 450
167. Wolfe K. C., Poma R., Syringomyelia in the cavalier king charles spaniel (CKCS) dog. Canadian Veterinary Journal 2010 51 1 95 102 2-s2.0-77249144061